BKYI Logo

BIO-key International, Inc. (BKYI) 

NASDAQ
Market Cap
$5.41M
Sector
Industrials
Industry
Security & Protection Services
Rank in Sector
378 of 520
Rank in Industry
18 of 23

Largest Insider Buys in Sector

BKYI Stock Price History Chart

BKYI Stock Performance

About BIO-key International, Inc.

BIO-key International, Inc. develops and markets fingerprint identification biometric technology and software solutions, and enterprise-ready identity access management solutions for commercial, government, and education customers in the United States and internationally. The company offers BIO-key PortalGuard and PortalGuard IDaaS solutions, a customer-controlled and neutral-by-design cloud-based identity platform that allows customers to integrate with any cloud or on-premises SaaS application, as well as windows device authentication through IAM platform. Its solutions enable its customers to secure their workforces and student populations; and make their partner networks more collaborative. In addition, it provides BIO-key VST and WEB-key products; and Civil and Large-Scale ID Infrastructure solutions that develops finger-based biometric technology. Further, it offers finger scanners for enterprise and consumer markets under SideSwipe, EcoID, and SidePass brand names. The company was formerly known as SAC Technologies and changed its name to BIO-key International, Inc. in 2002. BIO-key International, Inc. was founded in 1993 and is headquartered in Wall, New Jersey.

Insider Activity of BIO-key International, Inc.

Over the last 12 months, insiders at BIO-key International, Inc. have bought $0 and sold $0 worth of BIO-key International, Inc. stock.

On average, over the past 5 years, insiders at BIO-key International, Inc. have bought $74,822 and sold $0 worth of stock each year.

There was no buying activity among insiders over the last 12 months.

The last purchase of 20,000 shares for transaction amount of $3,600 was made by DEPASQUALE MICHAEL W (Chief Executive Officer) on 2023‑12‑01.

List of Insider Buy and Sell Transactions, BIO-key International, Inc.

2023-12-01PurchaseChief Executive Officer
20,000
0.1375%
$0.18$3,600-50.29%
2023-11-30PurchaseChief Legal Officer
20,000
0.102%
$0.17$3,300-57.07%
2023-11-27PurchaseChief Legal Officer
10,003
0.0726%
$0.16$1,644-40.97%
2023-11-24PurchaseChief Legal Officer
29,668
0.2105%
$0.16$4,862-44.44%
2023-10-30PurchaseChief Legal Officer
285,100
3.2231%
$0.17$49,893-37.15%
2023-10-30PurchaseChief Executive Officer
165,000
1.8653%
$0.17$28,875-37.15%
2023-09-15PurchaseChief Legal Officer
5,000
0.057%
$0.55$2,748-79.59%
2023-09-13PurchaseChief Executive Officer
5,000
0.0525%
$0.52$2,575-79.14%
2023-09-12PurchaseChief Executive Officer
100
0.001%
$0.51$51-79.87%
2023-09-11PurchaseChief Legal Officer
9,000
0.0968%
$0.53$4,750-79.87%
2023-08-31PurchaseChief Legal Officer
5,000
0.0563%
$0.55$2,750-78.76%
2023-06-16PurchaseChief Executive Officer
5,000
0.0541%
$0.71$3,575-77.78%
2022-09-15PurchaseChief Executive Officer
1,000
0.0123%
$1.69$1,688-54.44%
2022-09-14PurchaseChief Legal Officer
2,650
0.0329%
$1.62$4,293-51.88%
2022-09-14PurchaseChief Executive Officer
1,269
0.0156%
$1.60$2,030-51.88%
2022-09-12PurchaseChief Legal Officer
968
0.0119%
$1.57$1,520-50.96%
2022-09-08PurchaseChief Legal Officer
2,377
0.0284%
$1.52$3,613-50.64%
2022-08-24PurchaseChief Legal Officer
5,005
0.0616%
$1.72$8,584-54.39%
2022-06-14PurchaseChief Executive Officer
2,000
0.0244%
$1.66$3,320-49.40%
2022-06-14PurchaseChief Legal Officer
3,416
0.0424%
$1.69$5,764-49.40%

Insider Historical Profitability

<0.0001%
Kwok Fong WongManaging Director, BIO-key HK
4390708
140.4105%
$1.73220
Colatosti Thomas J.director
1134405
36.2772%
$1.73160
FODERO RANDYVP, Sales
482800
15.4395%
$1.7320
Sullivan James DavidChief Legal Officer
388171
12.4133%
$1.73180<0.0001%
DEPASQUALE MICHAEL WChief Executive Officer
306827
9.812%
$1.73210<0.0001%
Gilley Thomasdirector
79972
2.5574%
$1.7310
Michel Robert Jdirector
11571
0.37%
$1.7310

Institutional Investor Ownership

Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.